Profound Medical Corp.
PRN.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 49.18% | -46.35% | -101.05% | 43.04% | -35.35% |
| Total Depreciation and Amortization | 4.26% | -13.50% | -23.11% | -0.93% | -8.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.44% | 40.47% | 169.11% | -42.47% | -18.33% |
| Change in Net Operating Assets | -1,043.17% | -70.72% | 263.19% | -146.12% | 578.67% |
| Cash from Operations | 30.05% | -65.93% | -46.81% | 17.35% | -9.76% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 44.55% | 11.66% | 1.99% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 100.00% | -100.81% | 6,122.47% | 1.82% |
| Foreign Exchange rate Adjustments | -130.13% | 2,565.96% | 104.23% | -580.95% | 265.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.73% | -32.54% | -130.51% | 499.50% | 2.04% |